Growth Without Compromise: Building The Future of Medicines Sustainably
Through intentional design, renewable energy investments and a deep commitment to innovation and efficiency, we can redefine what responsible growth looks like.
Building Agile Pharmaceutical Programs That Stand Strong Amid Global Health Uncertainty
A promising program can be quickly be derailed by external instability. To prevent this in the future, leaders must ask these essential questions from the start.
presented by
Broadening Biomarker Validation for Alzheimer’s Disease Diagnosis Globally
Demonstrating the clinical utility and cost-effectiveness of innovative blood-based biomarker tests can help pave the way for making timely AD diagnosis and proactive care the norm.
Navigating Diagnostic Deserts: How Portable Ultrasound is Improving Maternal Healthcare in Africa
Providing affordable point-of-care diagnostic tools can be instrumental in quickly and efficiently assessing the well-being of all people, especially pregnant mothers. This can empower healthcare providers to be better diagnosticians and improve overall patient care, particularly for those at risk.
Navigating Complex Regulatory Landscapes in the Biopharmaceutical Industry
It is imperative to understand the various regulatory variations globally, develop a strategy for new technologies, engage in harmonization activities, and implement risk management measures.
Patients Everywhere Deserve Safer Care – Here’s How We Get There
Healthcare organizations tend to view issues in pockets – how they are impacting their specific organization and region – but patient safety is a collective mission. No matter what hospital or health system they are in, or which care model they belong to, patients everywhere deserve safer care.
presented by
Inside an Automated Healthcare Practice: Redesigning Care Around People, Not Paperwork
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
What the Ebola Outbreak Reveals about Pandemic Preparedness
The enduring legacy of the Ebola crisis serves as a poignant reminder of our shared responsibility in safeguarding public health and preventing future pandemics.
AWS to Infuse Another $20M Into Its Health Equity Program
AWS is funneling an additional $20 million into its health equity initiative, bringing the company’s total investment in the program to $60 million. As AWS continues to advance the mission of this program, the company is focusing on three main priorities: increasing access to high quality care, building resilient communities, and mitigating the harmful effects of climate change.
What We Can Learn From Health Systems Around the World
I am a practicing UK general practitioner and in this article, I take a magnifying glass to quality indicators including access, affordability, healthcare inequalities and population health, staffing and equipment, and patient and provider experience to discuss how we can shape up.
Microsoft commits $40M to AI for Health initiative
Microsoft’s latest effort will provide resources to researchers and nonprofits working to improve healthcare. The company is primarily focusing on three areas: medical research, global health, and access to care.
presented by
The Power of Real World Data to Study Women’s Health at Scale
Veradigm examines key clinical trends, comorbidity profiles, and treatment trends across adolescence, reproductive years, and peri-/post-menopause. Download it today!
Five benefits to developing a global transparency policy
As clinical trial compliance and disclosure remain in the spotlight and more and more countries continue to establish regulations, it is more important now than ever for sponsors to adopt a Global Transparency Policy.
Global health startup PharmaJet with needle-free injectable device close to raising $5M
Golden, Colorado-based PharmaJet, which seeks to reduce needle-stick injury and waste, has developed a needle-free intradermal vaccine injector.